SynAct Pharma AB

ISIN SE0013409620Filings at the FI

At a glance

Most recent filing on July 23, 2020 — an option exercise by TJ Biotech Holding Aps on Jul 22, 2020.

We hold 6 visible filings, going back to July 7, 2020.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

5 of 6 shown

  • TJ Biotech Holding Aps Closely associated: Board of Director, Chief Strategy Officer / Styrelseledamot, CSO
    29,840 sharesOption exercise
    TradedJul 22, 2020FiledJul 23, 2020
  • GLCapital AB Closely associated: Chairman of the Board / Styrelseordförande
    29,840 sharesOption exercise
    TradedJul 22, 2020FiledJul 22, 2020
  • Terje Kalland Board of Director / Styrelseledamot
    29,840 sharesOption exercise
    TradedJul 22, 2020FiledJul 22, 2020
  • JSH Biotech ApS Closely associated: Board of Director / Styrelseledamot
    29,840 sharesOption exercise
    TradedJul 9, 2020FiledJul 15, 2020
  • Quantass ApS Closely associated: CEO, Chief executive officer
    29,840 sharesOption exercise
    TradedJul 10, 2020FiledJul 14, 2020